EE03855B1 - Alfusosiinhüdrokloriidi reguleeritult vabastav tablett - Google Patents

Alfusosiinhüdrokloriidi reguleeritult vabastav tablett

Info

Publication number
EE03855B1
EE03855B1 EEP199900090A EE9900090A EE03855B1 EE 03855 B1 EE03855 B1 EE 03855B1 EE P199900090 A EEP199900090 A EE P199900090A EE 9900090 A EE9900090 A EE 9900090A EE 03855 B1 EE03855 B1 EE 03855B1
Authority
EE
Estonia
Prior art keywords
controlled release
release tablet
alfuzosin hydrochloride
hydrochloride controlled
alfuzosin
Prior art date
Application number
EEP199900090A
Other languages
English (en)
Estonian (et)
Other versions
EE9900090A (et
Inventor
Xavier Jarreau Fran�ois
Maggi Lauretta
Conte Ubaldo
Grenier Pascal
Vergnault Guy
Dufour Alain
Rauch-Desanti Cl�mence
Original Assignee
Synthlabo
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03855(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9610551A external-priority patent/FR2752737B1/fr
Application filed by Synthlabo, Jagotec Ag filed Critical Synthlabo
Publication of EE9900090A publication Critical patent/EE9900090A/xx
Publication of EE03855B1 publication Critical patent/EE03855B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900090A 1996-08-29 1997-08-22 Alfusosiinhüdrokloriidi reguleeritult vabastav tablett EE03855B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9610551A FR2752737B1 (fr) 1996-08-29 1996-08-29 Comprime a liberation controlee de chlorhydrate d'alfuzosine
FR9704386 1997-04-10
PCT/FR1997/001515 WO1998008515A1 (fr) 1996-08-29 1997-08-22 Comprime a liberation controlee de chlorhydrate d'alfuzosine

Publications (2)

Publication Number Publication Date
EE9900090A EE9900090A (et) 1999-10-15
EE03855B1 true EE03855B1 (et) 2002-10-15

Family

ID=26232935

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900090A EE03855B1 (et) 1996-08-29 1997-08-22 Alfusosiinhüdrokloriidi reguleeritult vabastav tablett

Country Status (36)

Country Link
US (1) US6149940A (de)
EP (1) EP0938318B1 (de)
JP (1) JP3797388B2 (de)
KR (1) KR100364328B1 (de)
CN (2) CN1155382C (de)
AP (1) AP1107A (de)
AR (1) AR009312A1 (de)
AT (1) ATE200864T1 (de)
AU (1) AU724490B2 (de)
BG (1) BG63768B1 (de)
BR (1) BR9713237B1 (de)
CA (1) CA2264250C (de)
CO (1) CO4920217A1 (de)
CY (1) CY2284B1 (de)
CZ (1) CZ295066B6 (de)
DE (1) DE69704712T2 (de)
DK (1) DK0938318T3 (de)
EE (1) EE03855B1 (de)
ES (1) ES2159400T3 (de)
GR (1) GR3036291T3 (de)
HU (1) HU228007B1 (de)
IL (1) IL128146A (de)
IS (1) IS2091B (de)
MX (1) MXPA99001958A (de)
NO (1) NO326206B1 (de)
NZ (1) NZ334018A (de)
OA (1) OA10983A (de)
PL (1) PL191546B1 (de)
PT (1) PT938318E (de)
RU (1) RU2183459C2 (de)
SI (1) SI0938318T1 (de)
SK (1) SK284388B6 (de)
TR (1) TR199900289T2 (de)
TW (1) TW522023B (de)
UA (1) UA69374C2 (de)
WO (1) WO1998008515A1 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720471B1 (en) 1998-04-28 2004-04-13 The Procter & Gamble Company Absorbent articles having reduced rewet with distribution materials positioned underneath storage material
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
FR2784583B1 (fr) * 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
ES2270982T3 (es) * 2000-02-04 2007-04-16 Depomed, Inc. Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US7163696B2 (en) * 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
US7008979B2 (en) 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US6852238B2 (en) * 2002-08-29 2005-02-08 Steller Technology Company Layered tablet water treatment compositions and method of use
US7309444B2 (en) * 2002-08-29 2007-12-18 Stellar Technology Company Layered tablet water treatment compositions and method of use
CN1703200B (zh) 2002-09-20 2012-02-29 奥尔制药公司 隔离亚单元和相关组合物及方法
EP1556014A1 (de) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Alfuzosin enthaltende zusammensetzungen mit verzlängerter freisetzung
KR20070043806A (ko) * 2004-07-29 2007-04-25 사노피-아벤티스 ｐＨ에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine
US20060062846A1 (en) * 2004-09-17 2006-03-23 Cimex Pharma Ag Alfuzosin tablets and synthesis
US20060062845A1 (en) * 2004-09-17 2006-03-23 Cimex Pharma Ag Alfuzosin tablets and synthesis
ITMI20050391A1 (it) * 2005-03-11 2006-09-12 Ph & T S P A Formulazioni a rilascio controllato di alfuzosin
EP2671507A3 (de) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-Informatiksystem
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
JP5296531B2 (ja) 2005-05-05 2013-09-25 センシエント フレイバーズ エルエルシー βグルカン及びマンナンの製造
US20070185237A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles
US20090238776A1 (en) * 2005-11-09 2009-09-24 Arif Ali Baig Oral Care Compositions and Methods
US20070185233A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles
US7834066B2 (en) * 2005-11-09 2010-11-16 The Procter & Gamble Company Denture adhesive articles
US20070185235A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive compositions
US20070129460A1 (en) * 2005-11-09 2007-06-07 Jayanth Rajaiah Denture adhesive articles
US20070185236A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive compositions
US20070185232A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles
US8206742B2 (en) 2006-01-12 2012-06-26 Wockhardt Ltd. Sustained release compositions of alfuzosin
EP2013829A4 (de) 2006-05-02 2010-07-07 Proteus Biomedical Inc Patientenspezifische therapieformen
SI2719378T1 (sl) 2006-06-19 2016-11-30 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
US20080003286A1 (en) * 2006-06-29 2008-01-03 Sathya Narayana Vemula Sustained delivery alfuzosin compositions
EP2067475A4 (de) * 2006-09-26 2010-12-15 Astellas Pharma Inc Tacrolimus-zubereitung mit verzögerter freisetzung
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
WO2008052136A2 (en) 2006-10-25 2008-05-02 Proteus Biomedical, Inc. Controlled activation ingestible identifier
EP2069004A4 (de) 2006-11-20 2014-07-09 Proteus Digital Health Inc Persönliche gesundheitssignalempfänger mit aktiver signalverarbeitung
US20080138412A1 (en) * 2006-12-06 2008-06-12 Fu-Yung Lin Sustained release alfuzosin hydrochl formulation and method for their production
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
WO2008073388A2 (en) * 2006-12-11 2008-06-19 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making and methods of use
WO2008084698A1 (ja) 2006-12-28 2008-07-17 Astellas Pharma Inc. タクロリムス徐放性医薬組成物
EP3785599B1 (de) 2007-02-01 2022-08-03 Otsuka Pharmaceutical Co., Ltd. Systeme mit einnehmbaren ereignismarkern
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
WO2008102235A1 (en) * 2007-02-20 2008-08-28 Aurobindo Pharma Limited Controlled release formulations of alfuzosin
EP2124725A1 (de) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. Körperintegrierte vorrichtung mit multidirektionalem sender
EP2063771A1 (de) 2007-03-09 2009-06-03 Proteus Biomedical, Inc. Körperintegrierte vorrichtung mit ausfahrbarer antenne
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
ES2928197T3 (es) 2007-09-25 2022-11-16 Otsuka Pharma Co Ltd Dispositivo intracorpóreo con amplificación de señal de dipolo virtual
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
DK3235491T3 (da) 2008-03-05 2021-02-08 Otsuka Pharma Co Ltd Spiselige hændelsesmarkeringsenheder og systemer med multimodus-kommunikation
BRPI0913398A2 (pt) * 2008-06-04 2015-11-24 Procter & Gamble composição e métodos de adesivo para dentaduras
DK2313002T3 (en) 2008-07-08 2018-12-03 Proteus Digital Health Inc Data basis for edible event fields
CN104382598A (zh) 2008-08-13 2015-03-04 普罗透斯数字保健公司 一种产生识别器的方法
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
CA2750148C (en) 2009-01-06 2017-02-07 Proteus Biomedical, Inc. Pharmaceutical dosages delivery system
AU2010203625A1 (en) 2009-01-06 2011-07-21 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US20100183717A1 (en) * 2009-01-16 2010-07-22 Kristin Arnold Controlled-release formulations
GB2480965B (en) 2009-03-25 2014-10-08 Proteus Digital Health Inc Probablistic pharmacokinetic and pharmacodynamic modeling
BR122013009559A2 (pt) 2009-04-28 2019-08-06 Proteus Digital Health, Inc. Marcadores de evento de ingerível altamente confiável e métodos para usar os mesmos
EP2432458A4 (de) 2009-05-12 2014-02-12 Proteus Digital Health Inc Einnehmbarer ereignismarker mit verzehrbarem bestandteil
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
AU2011224486B2 (en) 2010-03-10 2014-08-14 The Procter & Gamble Company Denture adhesive compositions
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
WO2011127252A2 (en) 2010-04-07 2011-10-13 Proteus Biomedical, Inc. Miniature ingestible device
JP5905872B2 (ja) * 2010-04-07 2016-04-20 ルピン・リミテッド タペンタドールの制御放出医薬組成物
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
CN102475690B (zh) * 2010-11-30 2016-06-01 安国药品株式会社 内含盐酸阿夫唑嗪的缓释片剂
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
BR112014001397A2 (pt) 2011-07-21 2017-02-21 Proteus Biomedical Inc dispositivo, sistema e método de comunicação móvel
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
EP2874886B1 (de) 2012-07-23 2023-12-20 Otsuka Pharmaceutical Co., Ltd. Verfahren zur herstellung verzehrbarer ereignismarker mit einem verzehrbaren bestandteil
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
JP2016508529A (ja) * 2013-01-29 2016-03-22 プロテウス デジタル ヘルス， インコーポレイテッド 高度に膨張可能なポリマーフィルムおよびこれを含む組成物
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
JP6511439B2 (ja) 2013-06-04 2019-05-15 プロテウス デジタル ヘルス， インコーポレイテッド データ収集および転帰の査定のためのシステム、装置、および方法
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
WO2017078557A1 (ru) * 2015-11-05 2017-05-11 Анатолий Викторович ЗАЗУЛЯ Изготовление таблетки с механизмом повышения терапевтической эффективности лекарственного средства нанодозой аналога
SG10202101937PA (en) 2016-07-22 2021-03-30 Proteus Digital Health Inc Electromagnetic sensing and detection of ingestible event markers
WO2018081337A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.

Also Published As

Publication number Publication date
ATE200864T1 (de) 2001-05-15
AP1107A (en) 2002-09-20
IS4964A (is) 1999-01-29
US6149940A (en) 2000-11-21
DK0938318T3 (da) 2001-08-20
KR100364328B1 (ko) 2002-12-26
UA69374C2 (uk) 2004-09-15
CN1543954A (zh) 2004-11-10
CY2284B1 (en) 2003-07-04
PL191546B1 (pl) 2006-06-30
IL128146A0 (en) 1999-11-30
JP2000514462A (ja) 2000-10-31
WO1998008515A1 (fr) 1998-03-05
CZ295066B6 (cs) 2005-05-18
ES2159400T3 (es) 2001-10-01
TR199900289T2 (xx) 2000-12-21
NZ334018A (en) 1999-06-29
PL331862A1 (en) 1999-08-16
IS2091B (is) 2006-03-15
IL128146A (en) 2001-01-11
CN100335057C (zh) 2007-09-05
GR3036291T3 (en) 2001-10-31
NO990944D0 (no) 1999-02-26
BG103138A (en) 1999-09-30
OA10983A (fr) 2003-03-04
NO990944L (no) 1999-04-27
NO326206B1 (no) 2008-10-20
CA2264250A1 (en) 1998-03-05
HUP9903428A3 (en) 2000-04-28
MXPA99001958A (es) 2005-09-08
AU724490B2 (en) 2000-09-21
CO4920217A1 (es) 2000-05-29
EP0938318A1 (de) 1999-09-01
TW522023B (en) 2003-03-01
PT938318E (pt) 2001-10-30
DE69704712T2 (de) 2001-11-29
JP3797388B2 (ja) 2006-07-19
SK27099A3 (en) 1999-12-10
RU2183459C2 (ru) 2002-06-20
HUP9903428A2 (hu) 2000-02-28
CA2264250C (en) 2005-07-05
SI0938318T1 (en) 2001-12-31
HU228007B1 (en) 2012-08-28
AR009312A1 (es) 2000-04-12
HK1020875A1 (en) 2000-05-26
EP0938318B1 (de) 2001-05-02
KR20000035929A (ko) 2000-06-26
CZ65599A3 (cs) 1999-06-16
AU4020197A (en) 1998-03-19
EE9900090A (et) 1999-10-15
BR9713237B1 (pt) 2009-01-13
SK284388B6 (sk) 2005-02-04
BR9713237A (pt) 2000-04-04
AP9901470A0 (en) 1999-03-31
CN1155382C (zh) 2004-06-30
DE69704712D1 (de) 2001-06-07
BG63768B1 (bg) 2002-12-29
CN1228700A (zh) 1999-09-15

Similar Documents

Publication Publication Date Title
EE9900090A (et) Alfusosiinhüdrokloriidi reguleeritult vabastav tablett
IT1303444B1 (it) Dispositivo di rilascio di farmaci.
NO20002121D0 (no) Benzotiazol-protein-tyrosin-kinaseinhibitorer
EE200100134A (et) Kiiresti vabastav tablett
DE69826338D1 (de) Sicherheitsrückhalt
PT915701E (pt) Pastilha de bromidrato de gelantamina de dissolucao rapida
ID23874A (id) Obat
DE69736532D1 (de) Synchronisationsgerät
DE59707194D1 (de) Direkttablettierhilfsmittel
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
ID23735A (id) Tablet trovafloksasin mesilat
DE59802126D1 (de) Tablettentestgerät
DE69737220D1 (de) Synchronisationsgerät
FI951300A7 (fi) Alfutsosiinihydrokloridin hitaan vapautumisen galeenisia muotoja
DE59703450D1 (de) Tablettenprüfgerät
EE9800209A (et) Antiglükokortikoidne ravimaine
DK0906101T3 (da) Farmaceutiske præparater med langsom frigivelse indeholdende mizolastin
NO983259L (no) Famciclovir tabletter
DE69718704D1 (de) Tablett verwendende Steuerungsvorrichtung
ZA977766B (en) Tablet with controlled release of alfuzosin hydrochloride.
NO992244D0 (no) AIDS-legemiddel
KR970053768U (ko) 정
ID21262A (id) Progestagen kristalin
ES1034978Y (es) Ladrillo encastrable
UA1246S (uk) Таблетка фармацевтична

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231